Last reviewed · How we verify

NCT07185529

Predictors of Mortality in Multiple Trauma Patients

Completed Last updated 22 September 2025
What this trial tests

trial testing Data of the patients were obtained from patient observation files and hospital information system database. in Multiple Trauma/Injuries in 269 participants. Completed in 15 July 2025.

Timeline
1 January 2021
Primary endpoint
1 November 2023
15 July 2025

Quick facts

Lead sponsorMelike Cengiz
StatusCompleted
Study typeOBSERVATIONAL
Enrollment269
Start date1 January 2021
Primary completion1 November 2023
Estimated completion15 July 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Melike Cengiz

Who can join

18 and older, any sex, with Multiple Trauma/Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Trauma is a public health concern that causes serious financial and medical burdens worldwide. According to the World Health Organization, 4.4 million people die from traumatic injuries each year which account for about 8% of global deaths. Traumatic injuries are among the most common causes of mortality particularly in young individuals. It also has a negative economic impact due to the loss of labor. Determining the factors associated with mortality in the ICU follow-up and treatment of these patients is very important for clarifying these uncertainties and improving ICU outcomes. The main objective of the study was to ascertain the ICU processes of multipletrauma patients and the factors that may have an effect on mortality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Multiple Trauma/Injuries

Currently open trials in the same condition.

Other Melike Cengiz trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07185529.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing